mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R)

NCT04390464 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1167

Enrollment

OTHER

Sponsor class

Conditions

COVID19

Interventions

DRUG: Ravulizumab
DRUG: Baricitinib
OTHER: Standard of care

Sponsor

Cambridge University Hospitals NHS Foundation Trust